Skip to main content
Erschienen in: World Journal of Urology 4/2010

01.08.2010 | Original Article

Contemporary open partial nephrectomy is associated with diminished procedure-specific morbidity despite increasing technical challenges: a single institutional experience

verfasst von: Bruce R. Kava, Rosely De Los Santos, Rajinikanth Ayyathurai, Samir Shirodkar, Murugesan Manoharan, Raymond Leveillee, Vincent Bird, Gaetano Ciancio, Mark S. Soloway

Erschienen in: World Journal of Urology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

To review trends in open partial nephrectomy (OPN) at our center, concentrating on patient selection, technique and perioperative complications.

Methods

A comprehensive database was developed by chart review of consecutive patients undergoing OPN for renal masses at our center. Patient selection, technical modifications, perioperative morbidity, and histopathology were compared in patients undergoing OPN between 1992–1999, 2000–2003, and 2004–2008. Complications were divided into procedure-specific (PSCs) and nonspecific medical complications (NMCs). They were graded using the Common Terminology Criteria for Adverse Events (CTCAE), version 3.0.

Results

One hundred and sixty-three OPNs were performed. Temporal trends identified include: an increase in the mean patient BMI (p = 0.04), an increase in the percentage of patients with central tumors (p < 0.001), decrease in cold ischemia time (p = 0.045), increasing use of a sequential renal vein clamp (p = 0.03), increasing utilization of tissue sealants (p < 0.001), reduced EBL (p = 0.05), reduced length of stay (p = 0.005), and a decline in PSCs from 16 to 7% (p = 0.002). The incidence of histologically benign tumors declined from 34 to 10% (p = 0.001). Thirty-three (20.2%) patients experienced perioperative complications: 70% were CTCAE grade 1 or 2 adverse events. BMI was the only factor that was found to be associated with the risk of complications on multivariate analysis [odds ratio 1.067, CI 95% (1.002–1.136); p = 0.031].

Conclusions

Increasingly, OPN is being utilized for a cohort of challenging patients who are overweight and have centrally located tumors. Despite this, the risk of PSCs is low. Patients who are overweight are at increased risk for perioperative NMCs.
Literatur
1.
Zurück zum Zitat Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163:44–45 Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163:44–45
2.
Zurück zum Zitat Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P (2000) Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol 163:730–736CrossRefPubMed Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P (2000) Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol 163:730–736CrossRefPubMed
3.
Zurück zum Zitat Lerner SE, Hawkins CA, Blute ML et al (1996) Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 155:1868–1873CrossRefPubMed Lerner SE, Hawkins CA, Blute ML et al (1996) Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 155:1868–1873CrossRefPubMed
4.
Zurück zum Zitat Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR (1995) Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology 45:34–40 (discussion 40–1)CrossRefPubMed Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR (1995) Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology 45:34–40 (discussion 40–1)CrossRefPubMed
5.
Zurück zum Zitat Belldegrun A, Tsui KH, deKernion JB, Smith RB (1999) Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 17:2868–2875PubMed Belldegrun A, Tsui KH, deKernion JB, Smith RB (1999) Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 17:2868–2875PubMed
6.
Zurück zum Zitat Uzzo RG, Wei JT, Hafez K, Kay R, Novick AC (1999) Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma. Urology 54:994–998CrossRefPubMed Uzzo RG, Wei JT, Hafez K, Kay R, Novick AC (1999) Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma. Urology 54:994–998CrossRefPubMed
7.
Zurück zum Zitat Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG, Practice Guidelines Committee of the American Urological Association (2009) Guidelines for the management of the clinical T1 renal mass. JUrol 182:1271–1279 Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG, Practice Guidelines Committee of the American Urological Association (2009) Guidelines for the management of the clinical T1 renal mass. JUrol 182:1271–1279
8.
Zurück zum Zitat Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ, Sinescu IC (2007) European Association of Urology Guideline Group for renal cell carcinoma. Eur Urol 51(6):1502–1510CrossRefPubMed Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ, Sinescu IC (2007) European Association of Urology Guideline Group for renal cell carcinoma. Eur Urol 51(6):1502–1510CrossRefPubMed
9.
Zurück zum Zitat Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML (2005) Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol 174:855–858CrossRefPubMed Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML (2005) Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol 174:855–858CrossRefPubMed
10.
Zurück zum Zitat Herr HW (1999) Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol 161:33–34 (discussion 34–5)CrossRefPubMed Herr HW (1999) Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol 161:33–34 (discussion 34–5)CrossRefPubMed
11.
Zurück zum Zitat Denzinger S, Ganzer R, Fink A, Wieland WF, Blana A (2007) Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up. Scand J Urol Nephrol 41(6):496–500CrossRefPubMed Denzinger S, Ganzer R, Fink A, Wieland WF, Blana A (2007) Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up. Scand J Urol Nephrol 41(6):496–500CrossRefPubMed
12.
Zurück zum Zitat Bhayani SB, Belani JS, Hidalgo J, Figenshau RS, Landman J, Venkatesh R, Kibel AS (2006) Trends in nephron-sparing surgery for renal neoplasia. Urology 68:732–736CrossRefPubMed Bhayani SB, Belani JS, Hidalgo J, Figenshau RS, Landman J, Venkatesh R, Kibel AS (2006) Trends in nephron-sparing surgery for renal neoplasia. Urology 68:732–736CrossRefPubMed
13.
Zurück zum Zitat Weight CJ, Fergamy AF, Gunn PW, Lane BR, Novick AC (2008) The impact of minimally invasive techniques on open partial nephrectomy: a 10-year single institutional experience. J Urol 180:84–88CrossRefPubMed Weight CJ, Fergamy AF, Gunn PW, Lane BR, Novick AC (2008) The impact of minimally invasive techniques on open partial nephrectomy: a 10-year single institutional experience. J Urol 180:84–88CrossRefPubMed
14.
Zurück zum Zitat Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques, and outcomes. J Urol 166:6–18CrossRefPubMed Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques, and outcomes. J Urol 166:6–18CrossRefPubMed
15.
Zurück zum Zitat National Cancer Institute website: Common terminology criteria for adverse events, version 3.0.; developed 2003 National Cancer Institute website: Common terminology criteria for adverse events, version 3.0.; developed 2003
16.
Zurück zum Zitat Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stockle M (2006) Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long-term survival data of 216 patients. Eur Urol 49:308–313CrossRefPubMed Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stockle M (2006) Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long-term survival data of 216 patients. Eur Urol 49:308–313CrossRefPubMed
17.
Zurück zum Zitat Drachenberg DE, Mena OJ, Choyke PL, Linehan WM, Walther MM (2004) Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers. J Urol 172:49–53CrossRefPubMed Drachenberg DE, Mena OJ, Choyke PL, Linehan WM, Walther MM (2004) Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers. J Urol 172:49–53CrossRefPubMed
18.
Zurück zum Zitat Hafez KS, Novick AC, Butler BP (1998) Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol 159:1156–1160CrossRefPubMed Hafez KS, Novick AC, Butler BP (1998) Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol 159:1156–1160CrossRefPubMed
19.
Zurück zum Zitat Black P, Filipas D, Fichtner J, Hohenfellner R, Thuroff JW (2000) Nephron sparing surgery for central renal tumors: experience with 33 cases. J Urol 163:737–743CrossRefPubMed Black P, Filipas D, Fichtner J, Hohenfellner R, Thuroff JW (2000) Nephron sparing surgery for central renal tumors: experience with 33 cases. J Urol 163:737–743CrossRefPubMed
20.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79CrossRefPubMed Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79CrossRefPubMed
21.
22.
Zurück zum Zitat Mendoza D, Newman RC, Albala D et al (1996) Laparoscopic complications in markedly obese urologic patients (a multi-institutional review). Urology 48:562–567CrossRefPubMed Mendoza D, Newman RC, Albala D et al (1996) Laparoscopic complications in markedly obese urologic patients (a multi-institutional review). Urology 48:562–567CrossRefPubMed
23.
Zurück zum Zitat Fazeli-Matin S, Gill IS, Hsu TH, Sung GT, Novick AC (1999) Laparoscopic renal and adrenal surgery in obese patients: comparison to open surgery. J Urol 162:665–669CrossRefPubMed Fazeli-Matin S, Gill IS, Hsu TH, Sung GT, Novick AC (1999) Laparoscopic renal and adrenal surgery in obese patients: comparison to open surgery. J Urol 162:665–669CrossRefPubMed
24.
Zurück zum Zitat Kutikov A, Fossett LK, Ramchandani P et al (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68:737–740CrossRefPubMed Kutikov A, Fossett LK, Ramchandani P et al (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68:737–740CrossRefPubMed
25.
Zurück zum Zitat Pahernik S, Ziegler S, Roos F, Mechior SW, Thuroff JW (2007) Small renal tumors: correlation of clinical and pathologic features with tumor size. J Urol 178:414–417CrossRefPubMed Pahernik S, Ziegler S, Roos F, Mechior SW, Thuroff JW (2007) Small renal tumors: correlation of clinical and pathologic features with tumor size. J Urol 178:414–417CrossRefPubMed
26.
Zurück zum Zitat Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P (2006) Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 176:2391–2396CrossRefPubMed Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P (2006) Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 176:2391–2396CrossRefPubMed
27.
Zurück zum Zitat Fujii Y, Komai Y, Saito K et al (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese Dual-Center Experience with 176 consecutive patients. Urology 72:598–602CrossRefPubMed Fujii Y, Komai Y, Saito K et al (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese Dual-Center Experience with 176 consecutive patients. Urology 72:598–602CrossRefPubMed
Metadaten
Titel
Contemporary open partial nephrectomy is associated with diminished procedure-specific morbidity despite increasing technical challenges: a single institutional experience
verfasst von
Bruce R. Kava
Rosely De Los Santos
Rajinikanth Ayyathurai
Samir Shirodkar
Murugesan Manoharan
Raymond Leveillee
Vincent Bird
Gaetano Ciancio
Mark S. Soloway
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 4/2010
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-010-0510-1

Weitere Artikel der Ausgabe 4/2010

World Journal of Urology 4/2010 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.